This application claims the benefit of Chinese Patent Application No. 201910775996.6 and Chinese Utility Model No. 201921364734.2, both filed Aug. 22, 2019, the disclosures of which are incorporated herein by reference.
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The present disclosure relates to a balloon dilation catheter and a balloon thereof, as an effective dilation device for percutaneous nephrolithotomy (PCNL) surgery, for example. In particular, the present disclosure relates to a balloon dilation catheter and a balloon thereof for easy identification.
Balloon dilatation catheters are currently widely used in many fields, including blood vessel dilation, stent placement, and creation of kidney calculi removal channels.
Desirable properties of balloon dilatation catheters are high burst pressure and distal positionability.
Distal Positionability
For doctors, it is desirable to determine a distal position of a balloon and an effective portion of the balloon in accidentally injured patients so as to better treat the patients.
For example, for percutaneous nephrolithotomy (PCNL), if blind puncture is performed during the dilation procedure, this will bring a high risk of puncture failure or damage to the renal parenchyma. Therefore, surgeons urgently need percutaneous devices (especially the distal end portion) that can be seen by medical imaging methods so as to reduce the risk during puncture. In the United States, a measure for visible PCNL is to perform surgery under X-ray such that a part of the device with X-ray opacity can be seen in images. However, it is commonly known that X-ray radiation is harmful to health of patients and doctors. Further, an X-ray image actually shows a two-dimensional structure instead of a three-dimensional structure, which makes it difficult to determine a penetration depth of the device.
In most balloon dilatation catheters on the market, the distal end is examined by fluoroscopy rather than ultrasound. In China, most doctors are willing to perform surgery under ultrasound guidance. However, since it is difficult to locate the medical device with ultrasound during surgery, accidental injuries may be caused to patients. Some doctors inject an ultrasound contrast agent into a body of a balloon for examination during an operation. However, the distal end of the balloon still cannot be visually seen.
Therefore, with the increasing need for PCNL under the help of ultrasonic examination, doctors and medical device manufacturers have noticed a safe medical image measure that does not cause radiation damage to patients and doctors. A device with echogenicity is displayed as a bright area, which is easy to be seen in a grayscale ultrasound image.
The echogenic medical device appears as a bright shadow in the grayscale image captured by a B-type ultrasonic instrument, enabling an operator to distinguish the difference in brightness between the medical device and a surrounding tissue in the image. A key factor in obtaining a bright shadow is that a probe can receive more backscatter from a surface of the device. In order to design a surface with higher backscatter, an interface with a high acoustic impedance difference (Z) should be created between the tissue and the surface of the medical device so that high frequency acoustic pulses can be reflected. Theoretically, the higher acoustic impedance difference at the interface should be set such that: the more the 180° reflection is, the better the echogenicity is detected. As shown in equation Z=ρ×v, Z is the product of density of material and propagation speed of sound wave in the material. Since the surrounding tissue and environment of the balloon dilator in the kidney during the PCNL is the renal cortex and renal pelvis filled with saline, the surface of the echogenic balloon dilator should have a significant density difference and a sound wave passing speed difference as compared to the renal cortex and renal pelvis.
An effective way is to create a gas-solid interface or a liquid-solid interface, because there are density difference and sound velocity difference between them. Among various materials, the Z value of air is extremely low, and the Z value of metal is higher than that of any polymer and liquid. Therefore, there are several ways to increase the difference in Z value at the interface, such as integrating metal materials, patterning the surface, or trapping gas at the device surface.
US2014/0243845A1 discloses a double-walled balloon catheter including an echogenic layer or sleeve made of 50%-85% metallic material mixed with polymer. US2013/0053770A1 also discloses a balloon catheter having at least two layers, one of which is made of a mixture of 80% tungsten and 20% polymer.
US2012/0277586A1 discloses an echogenic feeding tube having a metal sleeve, internal cannulas, or coiled ribbons or wrapped wires on the tubular member inside the balloon. US20080058702A1 discloses a catheter shaft which is wound with a coiled ribbon or a ribbon with a deformed surface. The metal part can also be processed by sand blasting, physical deformation or machining so as to have surface roughness and improve echogenicity.
US2008/0097213A1, US20150165160A1, U.S. Pat. Nos. 5,967,988 and 5,490,521A disclose various patterned surfaces for echogenic catheters and biopsy forceps. These patterns include spherical or hemispherical holes on a drainage catheter, laser-processed depressions with different angles on a surface of a cannula, convex, concave or other shapes of metal members embedded in a catheter body for coronary sinus perfusion.
Some examples of using gas, bubble, or fluid to improve echogenicity are listed as below. WO2007/102909A2 discloses an echogenicity blocking balloon by adding a polymer fluid cavity in a balloon body. U.S. Pat. No. 6,106,473 and WO98/19713 disclose porous polymer coatings with a large number of gas/non-gas interfaces, which are constructed by physical agitation and chemical reactions between mixed components that can release gas or H2O or are constructed only by volatilization of a volatile solvent. U.S. Pat. No. 6,506,156B1 discloses an echogenic coating with multiple pores or glass microsphere particles.
High Burst Pressure
Some materials are visible under ultrasound. However, it is difficult to combine these materials well with a balloon tip (also called as a neck) under a high pressure. If these materials are used to directly manufacture the balloon tip, a burst pressure of the balloon dilatation catheter will be greatly reduced.
At present, ultrasonic equipment and ultrasonic technology for detecting a target as accurately as an X-ray has not been fully developed, especially for complex detection environments. Since kidney calculi generally have high ultrasound echo signals (eg percutaneous nephrolithotomy), it is difficult to distinguish the balloon tip from the calculi under ultrasound, even if in the case where the balloon tip is made of a material with a high ultrasound echo signal.
Other Issues
During surgery, especially interventional surgery, it is difficult to measure the size of an affected area, such as the size of an aneurysm neck or the size of kidney calculi. Sometimes, it is important for doctors to get to know this information.
Further, for certain procedures (such as PCNL), only a portion of the balloon body is inserted into the patient. It is inconvenient for the surgeon to observe an insertion depth with naked eyes, so that the medical device cannot be placed correctly and may cause accidental injury.
The present disclosure aims to solve at least one of the above problems, and possibly others that have yet to be discovered.
According to one aspect of the present disclosure, a special balloon tip design (including the design of the shape) helps to identify the balloon tip.
According to another aspect of the present disclosure, a special balloon body design also helps to identify the balloon body.
According to yet another aspect of the present disclosure, adding scale marks on the balloon will help the surgeon visually observe an insertion depth such that a medical device can be correctly placed without causing accidental injury. By placing a balloon with scale marks close to an affected area, it is helpful to determine a size of the affected area.
According to an aspect of the present disclosure, there is provided a balloon for a balloon dilatation catheter, comprising, along an axial direction of the balloon, a balloon body, a balloon cone at each side of the balloon body, and a balloon tip extending from the balloon cone and fixed to the catheter, the balloon body and the balloon cone being formed of a plurality of polymer layers in a radial direction of the balloon, characterized in that the balloon tip comprises metal.
According to an embodiment, the balloon tip is made entirely of metal.
According to an embodiment, a plurality of notches are formed on the metal balloon tip.
According to an embodiment, the balloon tip, balloon body, and balloon cones are all formed of multiple polymer layers in the radial direction of the balloon, and the balloon tip is covered with a metal sleeve or cladding layer.
According to an embodiment, the metal sleeve or cladding layer is subjected to rough surface treatment.
According to an embodiment, the surface treatment is sand blasting, physical deformation or machining.
According to an embodiment, the balloon tip, balloon body, and balloon cones are all formed of multiple polymer layers in the radial direction of the balloon, and the balloon tip is provided with a plurality of metal cuffs spaced apart in the axial direction and extending in a circumferential direction.
According to an embodiment, a surface of the metal balloon tip is patterned to form a rectangular array, a triangular array, a hemispherical array, a diamond array, a cylindrical array, or a plurality of parallel grooves extending in the circumferential direction.
According to an embodiment, the patterned surface of the metal balloon tip is covered with a heat-shrinkable polymer coating.
According to an embodiment, the balloon tip, balloon body, and balloon cones are all formed of multiple polymer layers in the radial direction of the balloon, and the balloon tip is wound with a metal fiber.
According to an embodiment, a metal echogenic layer is provided under an outermost polymer layer of the balloon.
According to an embodiment, the metal echogenic layer includes a plurality of metal cuffs spaced apart in the axial direction and extending in the circumferential direction of the balloon.
According to an embodiment, the plurality of polymer layers include a polymer adhesive layer, and metal powder is mixed in the polymer adhesive layer.
According to an embodiment, the plurality of polymer layers include a polymer adhesive layer, and bubbles or pores are formed in the polymer adhesive layer.
According to an embodiment, the balloon tip, balloon body and balloon cones are all formed of multiple polymer layers in the radial direction of the balloon, an integral metal ring is provided on the balloon tip, a body of the ring is provided thereon with a plurality of circumferentially extending through grooves with opening directions opposite to each other and spaced apart from each other in the axial direction.
According to an embodiment, the balloon tip, balloon body and balloon cones are all formed of multiple polymer layers in the radial direction of the balloon, an integral metal ring is provided on the balloon tip, and a body of the ring is provided thereon with a continuously spiral through groove.
According to an embodiment, the balloon tip, balloon body and balloon cone are all formed of multiple polymer layers in the radial direction of the balloon, an integral metal ring is provided on the balloon tip, and a body of the ring is provided thereon with a plurality of axially disposed windows with every two adjacent rows of windows staggered from each other in the circumferential direction.
According to an embodiment, scale marks capable of reflecting ultrasonic waves are printed on an outer surface of the balloon body.
According to an embodiment, a first scale mark and scale marks at regular intervals therefrom are different in shape from other scale marks.
According to an embodiment, a starting position of the scale marks may start at a distal end of the balloon or at a distance from the balloon tip.
According to another aspect of the present application, there is provided a balloon dilatation catheter including the balloon as described above and a catheter passing through an interior of the balloon.
Other features of the present disclosure will become apparent from the following description of exemplary embodiments with reference to the drawings.
Hereinafter, embodiments of the present disclosure will be described with reference to the accompanying drawings. An echogenic balloon dilatation catheter is an example of an echogenic medical device, such as for PCNL. However, it should be noted that examples of an echogenic medical device are not limited thereto.
Depending on specific applications, the echogenic medical devices may be other medical devices known to those skilled in the art, such as abdominal medical devices, gynecological and obstetric medical devices, cardiac medical devices, and so on.
Embodiments described below serve only as specific examples. However, the present disclosure is not limited to the embodiments described in the description.
In general, as shown in
An Echogenic Balloon Having an Echogenic Tip
More specifically, the present disclosure relates to an echogenic tip of a balloon. A balloon with an echogenic tip can be identified from a surrounding tissue and saline injected into a renal pelvis. The present disclosure can enhance the difference in acoustic impedance between the tip of the balloon and the surrounding environment.
As shown in
A further modification is shown in
As shown in
As shown in
There is a determined pattern on a surface of the metal balloon tip.
In addition, the patterned surface the balloon tip can also be covered with a heat-shrinkable polymer coating. Due to an air gap on the patterned surface, air can be trapped between the balloon tip surface and the polymer coating so as to form an air/polymer interface, the interface having a large difference in acoustic impedance, thereby improving echogenicity.
Surface patterning can be achieved by machining on the final metal balloon tip, including laser lithography, etching, stamping or ball milling after the balloon tip is molded. As shown in
According to this embodiment, the tip of the echogenic balloon is wound with a metal fiber. The advantage thereof is that, on one hand, as compared to the interface between the polymer surface and the surrounding tissue, it provides an interface with a higher difference in acoustic impedance between the surface of the metal fiber and the surrounding tissue, and on the other hand, the irregular arrangement of the metal fiber layer provides an irregular surface with convexes and concaves. The fiber has a circular or rectangular shaped cross section, with a diameter of from about 0.05 mm to about 0.5 mm (for a circular cross section) or a side length of from about 0.01 mm to about 0.05 mm and from about 0.05 mm to about 0.25 mm. Metals include but are not limited to silver, platinum, gold, stainless steel, or silver-stainless steel composite material. Any metal that has good biocompatibility and can be extruded into a fiber can be used.
A Balloon Having an Echogenic Body and Cones
The present disclosure also relates to an echogenic balloon having an echogenic balloon body and balloon cones, used for percutaneous nephrolithotomy surgery.
As shown in
According to the present disclosure, an echogenic element can be added to the balloon so as to improve ultrasound echogenicity.
As shown in
According to this embodiment, it is also possible to mix metal powder in the polymer adhesive, which can increase the density of the entire composite. According to the present disclosure, in the polymer cladding layer 24 (which also serves as an adhesive layer) for adhering the polymer fiber layer 23 to the outermost polymer protective layer 25 or in the polymer adhesive layer 21 for adhering the polymer base layer 20 to the polymer film layer 22, metal powder is mixed, especially silver, titanium, nitinol, and gold powder, the metal powder having a particle size of from about 1 μm to about 10 μm, and a content of approximately 50% to approximately 80% such that density of the entire balloon is increased, thereby enhancing the echogenicity of the balloon body or cones.
According to this embodiment, it is also possible to use expansion/volatility effect of a poor solvent on a solvent-based adhesive so as to create pores in a polymer base layer of a balloon. In particular, the adhesive layer (for example, the polymer cladding layer 24 or the polymer adhesive layer 21) can be expanded by volatilization of the poor solvent. The solvent molecules penetrate into the polymer chain, but do not dissolve the polymer chain. Then, when the solvent volatilizes from the adhesive layer, the underlying polymer base layer of the balloon will shrink irregularly to form an irregular (e.g., convex and concave) surface, thereby forming echogenic gas pores. An interface between the polymer and gas pores provides a high acoustic impedance, which helps to improve echogenicity.
Further, the outermost polymer protective layer 25 may be omitted. In such a case, the polymer cladding layer 24 itself may be an adhesive. As such, it is advantageous to avoid the loss of adhesiveness caused by the formation of pores.
The following are some specific examples made according to the above embodiments:
1. Examples of an Echogenic Balloon Tip
1.1 In an example of an echogenic balloon, the tip of the balloon connected to the cone of the balloon is made of a metal material, in particular, titanium. The titanium tip of the balloon is adhered to the balloon cone. A large acoustic impedance difference between the titanium tip of the balloon and an organ tissue builds an interface on the tip with large acoustic wave backscattering, such that brightness of the titanium tip of the balloon is increased.
Another way to improve the echogenicity of the metal tip of the balloon is to form a hemispherical notch with a diameter of about 45 μm on the balloon tip by laser ablation. This also enhances the echogenicity of the balloon tip.
1.2 A metal cladding layer can be provided on the balloon tip. A stainless steel foil and a titanium foil with a thickness of about 0.05 mm are used to cover the balloon tip with the help of an adhesive so as to enhance the echogenicity.
Another way is to blast the titanium foil with a thickness of 0.05 mm and the stainless steel foil with a thickness of about 0.07 mm so as to form a rough surface with a roughness of 60-120 mesh. This rough cladding layer also enhances the echogenicity of the balloon tip.
1.3 A platinum, gold or silver cuff with a width of 1.0 mm and a thickness of 0.038 mm is adhered to the entire periphery of the balloon tip. Due to the enhanced backscattering of sound waves, brightness of the entire balloon tip is improved.
1.4 A stainless steel-silver composite fiber is used to wind around the balloon tip. A stainless steel-silver composite fiber with a diameter of about 0.076 mm is used to wind around the tip of the balloon as closely as possible. The wound composite fiber helps to greatly improve the echogenicity of the balloon tip.
1.5 A patterned balloon tip is made by machining. For example, a circle of groove is machined. As a result, an improved tip image identification is obtained, and the brightness in the grooved area is enhanced.
2. Examples of an Echogenic Balloon Body or Cone
2.1 A metal cuff is adhered to the balloon body. Particularly, a gold cuff can be adhered to the balloon body or cone to cover the entire cone. The gold cuff has a thickness of about 10 μm, and a width of about 1 mm. Echogenicity of the body or cone is improved.
2.2 A metal cuff is adhered to the balloon body. Particularly, a gold cuff can be adhered to the balloon body or cone to cover the entire cone. The gold cuff has a thickness of about 30 μm, and a width of about 1 mm. Echogenicity of the body or cone is improved.
2.3 A metal cuff is adhered to the balloon body. Particularly, a gold cuff can be adhered to the balloon body or cone to cover the entire cone. The gold cuff has a thickness of about 10 μm, and a width of about 2 mm. Echogenicity of the body or cone is improved.
2.4 Metal cuffs are adhered to the balloon body. Particularly, gold cuffs can be adhered to the balloon body or cone. The gold cuffs has a thickness of about 10 μm, and a width of about 1 mm, and an interval between adjacent gold cuffs is about 1 mm. Echogenicity of the body or cone is improved.
2.5 Metal cuffs are adhered to the balloon body. Particularly, gold cuffs can be adhered to the balloon body or cone. The gold cuffs has a thickness of about 30 μm, and a width of about 1 mm, and an interval between adjacent gold cuffs is about 1 mm. Echogenicity of the body or cone is improved.
2.6 A metal foil is adhered to the balloon body. Particularly, a stainless foil can be adhered to the balloon body or cone. The stainless cuff has a thickness of about 0.02 mm, and a width of about 1 cm. Echogenicity of the cone or body is improved.
2.7 A metal foil is adhered to the balloon body. Particularly, a titanium foil can be adhered to the balloon cone or body. The titanium foil has a thickness of about 0.05 mm, and a width of about 1 cm. Echogenicity of the cone or body is improved.
2.8 Metal powder is mixed in an adhesive between the layers. In particular, silver powder with a particle size of 6 μm is mixed into the adhesive at a content of about 50%. Echogenicity of the entire body or cone of the balloon is improved.
2.9 A layer of polyurethane adhesive is applied over a first polymer layer of the balloon (i.e. the layer that needs to be adhered to a second polymer layer). Then, a thin layer of dichloromethane or trichlormethane poor solvent is applied on top of the polyurethane adhesive to make it volatilize. Due to formation of pores in the polymer layer below the adhesive layer, echogenicity of the balloon is improved.
The above embodiments and examples improve the echogenicity of the balloon tip, balloon cone, or balloon body.
According to the present disclosure, the echogenicity of the balloon tip can also be improved by the following modifications.
A plurality of echogenic rings are mounted on the balloon tip at an axial interval. This is easy to manufacture and easy to perform ultrasonic examination.
A material for manufacturing the echogenic ring can be: a metal material with or without surface treatment; an alloy material with or without surface treatment; an polymer material with or without surface treatment and containing micro-bubbles; or any combination thereof.
Similar to the embodiment of
Compared to the mounting of a single ring on the balloon tip, since multiple echogenic rings are mounted on the balloon tip at an axial interval and the surface reflection of the echogenic ring material is stronger than the surface reflection of the balloon tip material 32, more echogenic surfaces can be obtained, such that ultrasound visibility and detectability of the balloon tip can be enhanced. Further, the balloon tip material in the interval between the rings helps to trap some air during use, which also helps to enhance the ultrasound visibility of the balloon tip.
On the other hand, due to the clinical requirements, the balloon tip is usually designed to be very short. Therefore, the echogenic ring should also be small so as to engage the balloon tip without excessively increasing an outer diameter and length of the balloon tip. However, it is difficult to engage multiple rings to the balloon tip at an axial interval. This problem can be solved by an integral echogenic ring.
(1) As shown in
(2) As shown in
(3) As shown in
For example, the specific design requirements of the above integral echogenic ring can be as follows:
Scale Marks
According to another aspect of the disclosure, scale marks 40 may be printed on an outer surface of the body of the balloon 10. The scale marks 40 are visible in fluoroscopy or ultrasound, and also visible to naked eyes. The scale marks can be used to measure an insertion depth of balloon, locate an effective portion of the balloon body, and measure an affected area during surgery. The scale marks may have an internal that may be from about 1 mm to about 20 mm, for example 10 mm.
For different application purposes, a starting position of the scale marks can start at a distal shoulder 14 of the balloon 10 so as to identify a position of the effective portion of the balloon. Alternatively, they can also start at a distance D from the tip 13 of the balloon, such as about 5 mm, so as to determine the catheter insertion depth.
For easy identification, a first scale mark and another scale mark at an interval (for example, about 50 mm) are different from other scale marks, for example, one is thicker than the other.
A material for the scale mark can be: a metal material with or without surface treatment; an alloy material with or without surface treatment; a polymer material with or without surface treatment and containing micro-bubbles; or any combination thereof.
Example 1 of Scale Marks:
As shown in
The number of scale marks is 16 in total. The first, sixth, eleventh and sixteenth scale marks are thicker than other scale marks.
In PCNL surgery, the doctor can measure the size of calculi by comparing the size of the calculi with these scale marks in fluoroscopy or ultrasound.
In aneurysm embolization using a balloon catheter, the doctor can measure a size of a tumor neck by comparing the size of the tumor neck with these scale marks in fluoroscopy or ultrasound.
Example 2 of Scale Marks:
As shown in
The number of scale marks is 12 in total. The first, sixth, and eleventh scale marks are thicker than other scale marks.
During PCNL surgery, the doctor needs to place the balloon in an appropriate position in the human body. The scale marks added on the outer surface of the balloon body can be used as scales to record an insertion depth of balloon. The doctor can insert the balloon and balloon catheter into the human body to a depth with naked eyes.
As used herein, the following terms have the following meanings:
“A”, “an”, and “the” as used herein refers to both singular and plural referents unless the context clearly dictates otherwise. By way of example, “a compartment” refers to one or more than one compartment.
“About,” “substantially,” or “approximately,” as used herein referring to a measurable value, such as a parameter, an amount, a temporal duration, and the like, is meant to encompass variations of +/−20% or less, preferably +/−10% or less, more preferably +/−5% or less, even more preferably +/−1% or less, and still more preferably +/−0.1% or less of and from the specified value, in so far such variations are appropriate to perform in the disclosed invention. However, it is to be understood that the value to which the modifier “about” refers is itself also specifically disclosed.
“Comprise”, “comprising”, and “comprises” and “comprised of” as used herein are synonymous with “include”, “including”, “includes” or “contain”, “containing”, “contains”, and are inclusive or open-ended terms that specifies the presence of what follows e.g. component and do not exclude or preclude the presence of additional, non-recited components, features, element, members, steps, known in the art or disclosed therein.
Although the invention has been described in conjunction with specific embodiments, many alternatives, modifications, and variations will be apparent to those skilled in the art. Accordingly, it embraces all such alternatives, modifications, and variations that fall within the appended claims' spirit and scope. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present disclosure.
Number | Date | Country | Kind |
---|---|---|---|
201921364734.2 | Aug 2019 | CN | national |
Number | Name | Date | Kind |
---|---|---|---|
6171248 | Hossack et al. | Jan 2001 | B1 |
6190915 | Madsen et al. | Feb 2001 | B1 |
6238343 | Madsen et al. | May 2001 | B1 |
6368277 | Mao | Apr 2002 | B1 |
6494860 | Rocamora | Aug 2002 | B2 |
6506156 | Jones | Jan 2003 | B1 |
6520934 | Lee et al. | Feb 2003 | B1 |
6540721 | Voyles | Apr 2003 | B1 |
6589262 | Honebrink | Jul 2003 | B1 |
6599237 | Singh | Jul 2003 | B1 |
6605943 | Clark | Aug 2003 | B1 |
6647132 | Montillo | Nov 2003 | B1 |
6663595 | Spohn | Dec 2003 | B2 |
6673060 | Fleming, III | Jan 2004 | B1 |
6692464 | Graf | Feb 2004 | B2 |
6723052 | Mills | Apr 2004 | B2 |
6733489 | Nutting | Apr 2004 | B2 |
6736803 | Cawood | May 2004 | B2 |
6796991 | Nardeo | May 2004 | B2 |
6748973 | Lindroos | Jun 2004 | B2 |
6892087 | Osypka | May 2005 | B2 |
6905458 | Choay et al. | Jun 2005 | B2 |
6939370 | Hartley | Sep 2005 | B2 |
7001369 | Griffin et al. | Feb 2006 | B2 |
7001396 | Glazier et al. | Feb 2006 | B2 |
7048717 | Frassica | May 2006 | B1 |
7101353 | Lui et al. | Sep 2006 | B2 |
7104979 | Jansen et al. | Sep 2006 | B2 |
7153277 | Skujins et al. | Dec 2006 | B2 |
7158692 | Chalana et al. | Jan 2007 | B2 |
7217256 | Di Palma | May 2007 | B2 |
7258669 | Russell | Aug 2007 | B2 |
7276062 | McDaniel et al. | Oct 2007 | B2 |
7306585 | Ross | Dec 2007 | B2 |
7314481 | Karpiel | Jan 2008 | B2 |
7322959 | Warnack et al. | Jan 2008 | B2 |
7462488 | Madsen et al. | Dec 2008 | B2 |
7481805 | Magnusson | Jan 2009 | B2 |
7510568 | Bleam et al. | Mar 2009 | B2 |
7524305 | Moyer | Apr 2009 | B2 |
7534250 | Schaeffer et al. | May 2009 | B2 |
7578814 | Accisano, III et al. | Aug 2009 | B2 |
7591813 | Levine et al. | Sep 2009 | B2 |
7655021 | Brasington et al. | Feb 2010 | B2 |
7677078 | Sauer et al. | Mar 2010 | B2 |
7678100 | Chin et al. | Mar 2010 | B2 |
7704245 | Dittman et al. | Apr 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
7736331 | Accisano, III et al. | Jun 2010 | B2 |
7780715 | Shaked et al. | Aug 2010 | B2 |
7794402 | Wang | Sep 2010 | B2 |
7833597 | Bavaro et al. | Nov 2010 | B2 |
7857820 | Skakoon et al. | Dec 2010 | B2 |
7874987 | Altmann et al. | Jan 2011 | B2 |
7875021 | Minassians | Jan 2011 | B2 |
7879024 | Thorstenson et al. | Feb 2011 | B2 |
7909798 | Osypka | Mar 2011 | B2 |
7909814 | Accisano, III et al. | Mar 2011 | B2 |
7922696 | Tal et al. | Apr 2011 | B2 |
7951093 | Skujins et al. | May 2011 | B2 |
7961929 | Ni et al. | Jun 2011 | B2 |
7968038 | Dittman et al. | Jun 2011 | B2 |
7985232 | Potter et al. | Jul 2011 | B2 |
7993272 | Chomas et al. | Aug 2011 | B2 |
7993305 | Ye et al. | Aug 2011 | B2 |
8070694 | Galdonik et al. | Dec 2011 | B2 |
8105287 | Fisher et al. | Jan 2012 | B2 |
8137309 | Nishtala et al. | Mar 2012 | B2 |
8137317 | Osypka | Mar 2012 | B2 |
8147452 | Nardeo et al. | Apr 2012 | B2 |
8147456 | Fisher et al. | Apr 2012 | B2 |
8157790 | Kubo et al. | Apr 2012 | B2 |
8177770 | Rasmussen et al. | May 2012 | B2 |
8262671 | Osypka | Sep 2012 | B2 |
8273059 | Nardeo et al. | Sep 2012 | B2 |
8287585 | Gurm | Oct 2012 | B2 |
8292852 | Mulholland et al. | Oct 2012 | B2 |
8366674 | Frassica et al. | Feb 2013 | B2 |
8377083 | Mauch et al. | Feb 2013 | B2 |
8460323 | Mauch et al. | Jun 2013 | B2 |
8478383 | Bar-Tal et al. | Jul 2013 | B2 |
8500688 | Engel et al. | Aug 2013 | B2 |
8517993 | Freas et al. | Aug 2013 | B2 |
8591567 | Chau et al. | Nov 2013 | B2 |
8639310 | Chen et al. | Jan 2014 | B2 |
8652098 | Haslinger | Feb 2014 | B2 |
8696582 | Rohling | Apr 2014 | B2 |
8700129 | Hauck et al. | Apr 2014 | B2 |
8734426 | Ahmed et al. | May 2014 | B2 |
8753313 | Kimmel et al. | Jun 2014 | B2 |
8771225 | Ahn | Jul 2014 | B2 |
8795311 | Griffith et al. | Aug 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8834499 | Mauch et al. | Sep 2014 | B2 |
8845614 | Raabe et al. | Sep 2014 | B2 |
8888787 | Wynberg | Nov 2014 | B2 |
8906268 | Boutet et al. | Dec 2014 | B2 |
8911400 | Ferry | Dec 2014 | B2 |
8926560 | Dinh et al. | Jan 2015 | B2 |
8948474 | Chang et al. | Feb 2015 | B2 |
8986283 | Rajendran et al. | Mar 2015 | B2 |
8998814 | Oikawa et al. | Apr 2015 | B2 |
9044266 | Nimgaard | Jun 2015 | B2 |
9044577 | Bishop et al. | Jun 2015 | B2 |
9060756 | Bencini et al. | Jun 2015 | B2 |
9089672 | Hendriksen et al. | Jul 2015 | B2 |
9126019 | Guo et al. | Sep 2015 | B2 |
9149176 | Greenberg et al. | Oct 2015 | B2 |
9149606 | Beissel et al. | Oct 2015 | B2 |
9174036 | Okamura et al. | Nov 2015 | B2 |
9186484 | Defossez et al. | Nov 2015 | B2 |
9233226 | Lampropoulos et al. | Jan 2016 | B2 |
9241735 | Nishtala et al. | Jan 2016 | B2 |
9242076 | Burton et al. | Jan 2016 | B2 |
9248261 | Schweikert et al. | Feb 2016 | B2 |
9254146 | Massengale et al. | Feb 2016 | B2 |
9282945 | Smith et al. | Mar 2016 | B2 |
9314749 | Yagi et al. | Apr 2016 | B2 |
9352132 | Urie | May 2016 | B2 |
9393041 | Barker et al. | Jul 2016 | B2 |
9398936 | Razzaque et al. | Jul 2016 | B2 |
9409001 | Aggerholm et al. | Aug 2016 | B2 |
9420992 | Sheldon et al. | Aug 2016 | B2 |
9445837 | Fulton, III | Sep 2016 | B2 |
9474882 | Franklin | Oct 2016 | B2 |
9492638 | McKinnis et al. | Nov 2016 | B2 |
9498282 | Fernald | Nov 2016 | B2 |
9504476 | Gulachenski | Nov 2016 | B2 |
9517185 | Al-Jazaeri | Dec 2016 | B1 |
9522253 | Gandras et al. | Dec 2016 | B2 |
9538981 | Rioux et al. | Jan 2017 | B2 |
9539415 | Racz et al. | Jan 2017 | B2 |
9545506 | Quigley | Jan 2017 | B2 |
9566087 | Bierman et al. | Feb 2017 | B2 |
9566413 | Eberhardt et al. | Feb 2017 | B2 |
9629981 | Thungana et al. | Apr 2017 | B2 |
9655594 | Oraevsky et al. | May 2017 | B2 |
9668654 | Rajendran et al. | Jun 2017 | B2 |
9693820 | Potter et al. | Jul 2017 | B2 |
9706988 | Nobles et al. | Jul 2017 | B2 |
9717884 | Matsumoto et al. | Aug 2017 | B2 |
9737284 | Kim et al. | Aug 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9764117 | Bierman et al. | Sep 2017 | B2 |
9773307 | Chang et al. | Sep 2017 | B2 |
9839770 | Linden et al. | Dec 2017 | B2 |
9861385 | Fulton | Jan 2018 | B2 |
9872666 | Quearry | Jan 2018 | B2 |
9877704 | Ogawa | Jan 2018 | B2 |
9884169 | Bierman et al. | Feb 2018 | B2 |
9920188 | Vogt et al. | Mar 2018 | B2 |
9950158 | True et al. | Apr 2018 | B2 |
9955940 | Coats et al. | May 2018 | B1 |
9972082 | Holsing et al. | May 2018 | B2 |
9980699 | Quearry et al. | May 2018 | B2 |
10004475 | Quearry | Jun 2018 | B2 |
10010701 | Ahmed et al. | Jul 2018 | B2 |
10034655 | McKinnis et al. | Jul 2018 | B2 |
10074037 | Lu et al. | Sep 2018 | B2 |
10076307 | Coats et al. | Sep 2018 | B2 |
10080873 | Stapleton et al. | Sep 2018 | B2 |
10086174 | Crall et al. | Oct 2018 | B2 |
10111645 | Fearnot et al. | Oct 2018 | B2 |
10118027 | Seifert et al. | Nov 2018 | B2 |
10137020 | Treacy et al. | Nov 2018 | B2 |
10143455 | Lichty, II et al. | Dec 2018 | B2 |
10166070 | Davies et al. | Jan 2019 | B2 |
10169641 | Lee et al. | Jan 2019 | B2 |
10173033 | Leung et al. | Jan 2019 | B2 |
10182804 | Walters et al. | Jan 2019 | B2 |
10183147 | Yang et al. | Jan 2019 | B2 |
10188371 | Madsen et al. | Jan 2019 | B2 |
10213582 | Garrison et al. | Feb 2019 | B2 |
10213583 | Klocke et al. | Feb 2019 | B2 |
10219788 | Tabeie | Mar 2019 | B2 |
10220192 | Drasler et al. | Mar 2019 | B2 |
10226203 | Stigall et al. | Mar 2019 | B2 |
10226264 | McIntosh et al. | Mar 2019 | B2 |
10238463 | Verstege et al. | Mar 2019 | B2 |
10238834 | Bridgeman et al. | Mar 2019 | B2 |
10249037 | Chang et al. | Apr 2019 | B2 |
10252028 | Katsurada et al. | Apr 2019 | B2 |
20060182873 | Klisch | Aug 2006 | A1 |
20080132933 | Gerber | Jun 2008 | A1 |
20090030370 | Nishtala et al. | Jan 2009 | A1 |
20100234875 | Allex | Sep 2010 | A1 |
20110181614 | Chang et al. | Jul 2011 | A1 |
20110224538 | Linares | Sep 2011 | A1 |
20120209176 | Anderson | Aug 2012 | A1 |
20120232528 | Eli | Sep 2012 | A1 |
20130103004 | Gray et al. | Apr 2013 | A1 |
20130190609 | Fischer, Jr. | Jul 2013 | A1 |
20130226094 | Ahmed et al. | Aug 2013 | A1 |
20140180068 | Spencer et al. | Jun 2014 | A1 |
20140206987 | Urbanski et al. | Jul 2014 | A1 |
20140221828 | McKinnis et al. | Aug 2014 | A1 |
20140257090 | Fischer, Jr. et al. | Sep 2014 | A1 |
20140265024 | Quearry | Sep 2014 | A1 |
20140276073 | Quearry | Sep 2014 | A1 |
20150086094 | Chang et al. | Mar 2015 | A1 |
20150086095 | Chang et al. | Mar 2015 | A1 |
20150112256 | Byrne et al. | Apr 2015 | A1 |
20150150586 | Aggerholm et al. | Jun 2015 | A1 |
20150272542 | Shuman et al. | Oct 2015 | A1 |
20150273120 | Zamarripa et al. | Oct 2015 | A1 |
20150320979 | Fearnot et al. | Nov 2015 | A1 |
20160120509 | Syed et al. | May 2016 | A1 |
20160128718 | Aggerholm et al. | May 2016 | A1 |
20160193448 | Nardeo et al. | Jul 2016 | A1 |
20160223308 | Rhee et al. | Aug 2016 | A1 |
20160331929 | Lampropoulos et al. | Nov 2016 | A1 |
20170021139 | Bajema et al. | Jan 2017 | A1 |
20170032557 | Anand et al. | Feb 2017 | A1 |
20170049997 | Chao et al. | Feb 2017 | A1 |
20170112528 | Crisman et al. | Apr 2017 | A1 |
20170135908 | Tai et al. | May 2017 | A1 |
20170143349 | Raabe et al. | May 2017 | A1 |
20170151415 | Maeda et al. | Jun 2017 | A1 |
20170173302 | Beasley et al. | Jun 2017 | A1 |
20170182297 | Lysgaard et al. | Jun 2017 | A1 |
20170182304 | Bagwell et al. | Jun 2017 | A1 |
20170189059 | Long, Jr. et al. | Jul 2017 | A1 |
20170224967 | Gorn et al. | Aug 2017 | A1 |
20170232231 | Neoh et al. | Aug 2017 | A1 |
20170252560 | Imran | Sep 2017 | A1 |
20170296798 | Kume et al. | Oct 2017 | A1 |
20170333149 | Stigall et al. | Nov 2017 | A1 |
20170333682 | Nardeo | Nov 2017 | A1 |
20170368238 | Robinson | Dec 2017 | A1 |
20180001063 | Aggerholm et al. | Jan 2018 | A1 |
20180008237 | Venkataraman et al. | Jan 2018 | A1 |
20180015277 | Stephens et al. | Jan 2018 | A1 |
20180036033 | Ignagni et al. | Feb 2018 | A1 |
20180093073 | Shimizu et al. | Apr 2018 | A1 |
20180117279 | Yachia et al. | May 2018 | A1 |
20180126129 | McDonough | May 2018 | A1 |
20180132821 | Dehghan Marvast et al. | May 2018 | A1 |
20180169383 | Khalaj et al. | Jun 2018 | A1 |
20180177980 | Khalaj et al. | Jun 2018 | A1 |
20180200491 | Giasolli | Jul 2018 | A1 |
20180214288 | Smouse et al. | Aug 2018 | A1 |
20180221649 | Mulrooney et al. | Aug 2018 | A1 |
20180243046 | Scott et al. | Aug 2018 | A1 |
20180256849 | Linden et al. | Sep 2018 | A1 |
20180256907 | Katra et al. | Sep 2018 | A1 |
20180263595 | Goksel et al. | Sep 2018 | A1 |
20180272039 | Kim et al. | Sep 2018 | A1 |
20180296186 | Harks et al. | Oct 2018 | A1 |
20180296804 | Bierman | Oct 2018 | A1 |
20180360494 | Melsheimer | Dec 2018 | A1 |
20190001031 | Real et al. | Jan 2019 | A1 |
20190015638 | Gruba et al. | Jan 2019 | A1 |
20190053790 | Grover et al. | Feb 2019 | A1 |
20190059857 | Ogura et al. | Feb 2019 | A1 |
20190076166 | Bierman et al. | Mar 2019 | A1 |
20190076167 | Fantuzzi et al. | Mar 2019 | A1 |
20190083061 | Choi | Mar 2019 | A1 |
20190091453 | Browne et al. | Mar 2019 | A1 |
20190091461 | Bonham et al. | Mar 2019 | A1 |
20190105466 | Schibli et al. | Apr 2019 | A1 |
20190105474 | Sheibley | Apr 2019 | A1 |
20190110795 | Koo et al. | Apr 2019 | A1 |
20190125318 | Sarna et al. | May 2019 | A1 |
20190125398 | Baldwin et al. | May 2019 | A1 |
Entry |
---|
David Lewis, My patient is injured: Identifying foreign bodies with ultrasound, 2015, U.S. National Library of Medicine, Ultrasound vol. 23 (3), 174-180 (Year: 2015). |
Number | Date | Country | |
---|---|---|---|
20210052861 A1 | Feb 2021 | US |